F9013180032
Phase IIb Study of F901318 As Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options
Treatment
- open-label single-arm of F901318 as treatment of invasive fungal infections
Inclusion criteria
- 18 years or older
- Patients with invasive fungal disease
Exclusion criteria
- Patients with chronic aspergillosis
Participating sites
- University Hospital Leuven Gasthuisberg
- Institut Jules Bordet